Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

Clinical trial NCT07044544 · RECRUITING

Trial details

NCT number: NCT07044544
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Myeloid Malignancy Hematologic Malignancy Acute Myeloid Leukemia Myelodysplastic Syndromes

Start date: 2025-07-17
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.